Novas perspectivas no tratamento da doença degenerativa discal

Acta Reumatologica Portuguesa

Volumn 34, Issue 2 B, 2009, Pages 327-335

  da Silva, Manuel Ribeiro ^a   Domingues, Cristina João ^a   Pinto, Rui Peixoto ^a   Neves, Nuno ^a   Matos, Rui Milheiro ^a   Tulha, José Manuel ^a   Cabral, Abel Trigo ^a  

^a University of Porto   (Portugal)

Author keywords

Biologic therapy; Degenerative disc disease; Genetic therapy; Intervertebral disc; Stem cells

Indexed keywords

GENE THERAPY; HUMAN; INTERVERTEBRAL DISK DEGENERATION; REVIEW; STEM CELL TRANSPLANTATION;

GENE THERAPY; HUMANS; INTERVERTEBRAL DISK DEGENERATION; STEM CELL TRANSPLANTATION;

EID: 79958096551     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Anderson GB. Epidemiology of low back pain. Acta Orthop Scand 1998;281:28-31.
2. Luoma K, Riihimaki H, Luukkonen R et al. Low back pain in relation to lumbar degeneration. Spine 2000;25:487-492.
3. Maetzel A, Li L. The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 2002;16:23-30.
4. Crevensten G, Walsh AJ, Ananthakrishnan D et al. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng 2004;32:430-434.
5. Gruber HE, Hanley EN Jr. Biologic strategies for the therapy of intervertebral disc degeneration. Expert Opin Biol Ther 2003;3:1209-1214.
6. Roberts S, Evans H, Trivedi J, Menage J. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 2006;88:10-14.
7. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine 2006;31: 2151- 2161.
8. Cassinelli EH, Hall RA, Kang JD. Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications. Spine J 2001;1:205-214.
9. Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol 2002;196:374-379.
10. Battié MC, Videman T. Lumbar disc degeneration: epidemiology and genetics. J Bone Joint Surg Am 2006;88:3-9.
11. Froes N, Nunes F, Negrelli W. Genetic influence on intervertebral disc degeneration. Acta Ortop Bras 2005;13:255-257.
12. Annunen S, Paassilta P, Lohiniva J et al. An allele of COL9A2 associated with intervertebral disc disease. Science 1999;285:409-412.
13. Jim JJ, Noponen-Hietala N, Cheung KM et al. The TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity of intervertebral disc degeneration. Spine 2005;30:2735-2742.
14. Gruber HE, Hanley EN Jr. Recent advances in disc cell biology. Spine 2003;28:186-193.
15. Selkirk SM. Gene therapy in clinical medicine. Postgrad Med J 2004;80:560-570.
16. Freemont AJ, Watkins A, Le Maitre C et al. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications of therapy. J Pathol 2002;196:374-379.
17. Wehling P, Schulitz KP, Robbins PD, Evans CH, Reinecke JA. Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine 1997;22:1092-1097.
18. Nishida K, Kang JD, Suh JK, Robbins PD, Evans CH, Gilbertson LG. Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration. Spine 1998;15;23:2437-2442.
19. Liu X, Li K, Song J, Liang C, Wang X, Chen X. Efficient and stable gene expression in rabbit intervertebral disc cells transduced with a recombinant baculovirus vector. Spine 2006;31:732-735.
20. Nishida K, Kang JD, Gilbertson LG et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 1999;24:2419-2425.
21. Moon SH, Gilbertson LG, Nishida K et al. Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine 2000;15;25:2573-2579.
22. Wallach CJ, Kim JS, Sobajima S et al. Safety assessment of intradiscal gene transfer: a pilot study. Spine J 2006;6:107-112.
23. Le Maitre CL, Freemont AJ, Hoyland JA. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. IntJ Exp Pathol 2006;87:17-28.
24. Le Maitre CL, Hoyland JA, Freemont AJ. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther 2007;9:R83.
25. Paul R, Haydon RC, Cheng H et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003;28:755-763.
26. Cui M, Wan Y, Anderson DG et al. Mouse growth and differentiation factor-5 protein and ADN therapy potentiates intervertebral disc cell aggregation and chondrogenic gene expression. Spine J 2008;8:287--295.
27. Wallach CJ, Kim JS, Sobajima S et al. Safety assessment of intradiscal gene transfer: a pilot study. Spine J 2006;6:107-112.
28. Vadalà G, Sowa GA, Smith L et al. Regulation of transgene expression using an inducible system for improved safety of intervertebral disc gene therapy. Spine 2007;32:1381-1387.
29. Nishida K, Doita M, Takada T et al. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine 2006;31:1415-1419.
30. Chung SA, Wei AQ, Connor DE et al. Nucleus pulposus cellular longevity by telomerase gene therapy. Spine 2007;32:1188-1196.
31. Gruber HE, Johnson TL, Leslie K et al. Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine 2002;27: 1626-1633
32. Yamamoto Y, Mochida J, Sakai D et al. Upregulation of the viability of nucleus pulposus cells by boné marrow-derived stromal cells: significance of direct cellto-cell contact in coculture system. Spine 2004:1508--1514.
33. Klein RG, Eek BC, O'Neill CW et al. Biochemical injection treatment for discogenic low back pain: a pilot study. Spine J 2003;3:220-226.
34. Kroeber MW, Unglaub F, Wang H et al. New in vivo animal model to create intervertebral disc degeneration and to investigate the effects of therapeutic strategies to stimulate disc regeneration. Spine 2002;27:2684-2690.
35. Risbud MV, Albert TJ, Guttapalli A et al. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine 2004;29: 2627-2632.
36. Risbud MV, Shapiro IM, Vaccaro AR et al. Stem cell regeneration of the nucleus pulposus. Spine J 2004;4:348-353
37. Steck E, Bertram H, Abel R et al. Induction of intervertebral disc-like cells from adult mesenchymal tem cells. Stem Cells 2005;23:403-411.
38. Zhang YG, Guo X, Xu P et al. Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans. Clin Orthop Relat Res 2005;430:219-226.
39. Sakai D, Mochida J, Yamamoto Y et al. Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potencial therapeutic model for disc degeneration. Biomaterials 2003,24:3531-3541.
40. Wakitani S, Imoto K, Yamamoto T et al. Human autologous culture expanded boné marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritic Cartilage 2002;10:199-206.
41. Walsh AJ, Bradford DS, Lotz JC. In vivo growth factor treatment of degenerated intervertebral discs. Spine 2004;29:156-163.